Atlas Trials

A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer

Clinical trial NCT02596373 · UNKNOWN

Trial details

NCT number
NCT02596373
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Recurrent or Metastatic Breast Cancer
Start date
2015-06-01
Primary completion
2018-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.